How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants

Recruiting N/A Interventional Study
Respiratory Distress Syndrome (Neonatal) Respiratory Distress of Newborn
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
10 (estimated)
Sponsor
University of Arkansas · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical * The infant must be stable while receiving nasal CPAP at any pressure level at the time of study * The infant must be receiving 22-40% at the…
Contacts

Nicholas A Rowley, MD

940-230-5002

NARowley@uams.edu

CONTACT